Stay Updated with the Latest Trinity Biotech plc TRIB News in Real Time
Find TRIB news now at Meyka AI. Stay informed with the latest Trinity Biotech plc stocks updates, including price news, market analysis, and expert insights.
Q32 Bio (NASDAQ: QTTB) Jumps 60% on Strong 36-Week Clinical Data for Hair Loss Treatment
On 13 July 2026, Q32 Bio (NASDAQ: QTTB) became one of the biggest gainers in the biotech sector after its shares climbed about 60% on the back of positive 36-week Phase 2a clinical results for its experimental alopecia areata treatment, bempikibart. The latest data showed meaningful hair regrowth in patients with severe hair loss while…
ME Group (LSE: MEGP) Surges 13% After Reaffirming Full-Year Profit Outlook Despite April Slowdown
On 13 July 2026, ME Group International plc (LSE: MEGP) shares climbed about 13% after the company repeated its full-year profit guidance, even though trading slowed during April. Investors took the update as a sign that the weaker month did not reflect the company’s overall performance. Trading improved from May, while the Wash.ME laundry business…
EasyJet Shares Surge Over 10% as £5.5 Billion Castlelake Buyout Bid Enters Final Stages
On July 6, 2026, EasyJet shares jumped more than 10% after the British low-cost airline confirmed it had reached an agreement in principle with U.S. investment firm Castlelake on a £5.5 billion takeover proposal. The announcement lifted investor confidence and fueled expectations that one of the year’s biggest airline acquisitions could move ahead. While the…
Craneware (LON:CRW) Shares Plunge 23% to Lowest Level Since 2016 After Cutting FY Revenue Outlook
Craneware plc shares fell as much as 23% today, touching an intraday low of 988 pence. That marks the stock’s lowest level since November 28, 2016. The Edinburgh-based healthcare financial software firm issued an unscheduled trading update warning that full-year results would miss market expectations. Craneware now guides FY26 revenue to $205 million to $208…
Abivax Shares Jump 3.91% After $920 Million Stock Offering Grows Beyond Expectations
Abivax shares climbed 3.91% on Nasdaq on July 2, 2026, after the French biotech confirmed its $920 million American Depositary Share offering. Underwriters exercised their full option, pushing gross proceeds well past the original $600 million target. The ADS offering priced at $125.00 apiece on July 1. Abivax (Nasdaq: ABVX, Euronext Paris: ABVX) said the…
AlzeCure Shares Soar 71% to Highest Since 2022 on $2.2 Billion Alzheimer’s Drug Licensing Deal
AlzeCure shares surged 71% on June 30, 2026, reaching their highest level since early 2022 after the Swedish biotech company announced an Alzheimer’s drug licensing agreement valued at more than $2.2 billion, excluding royalties. The deal gives global development and commercialization rights to its lead candidate, ACD856, and marks a major milestone for the company….
Abivax Shares Soar 27% After Ulcerative Colitis Drug Shows Strong Results in Hard-to-Treat Patients
Abivax shares surged sharply after new clinical trial results for its ulcerative colitis treatment, obefazimod, showed strong performance in patients who previously failed standard therapies. The stock reaction reflects renewed investor confidence in the biotech pipeline and growing hopes for a breakthrough therapy in a difficult disease area. The move also comes at a time…
Moonpig (LON: MOON) Shares Jump 10% as FY26 Profit Beats Estimates Under New CEO
Moonpig Group (LON: MOON) delivered a standout performance on June 25, 2026. Shares jumped over 10% after the online greeting card and gifting company reported full-year profit ahead of analyst forecasts. Adjusted earnings per share rose 19.5% the first annual results since CEO Catherine Faiers joined in March. The numbers beat on every key metric:…
NVDA Stock Rises 0.8% in Early Market as AEGON Asset Management UK Plc Sells 176,898 Shares of NVIDIA Corporation
NVDA stock opened with quiet resilience on June 25, 2026, rising approximately 0.8% in early trading. NVIDIA’s opening price was $202.17, with the day’s range spanning $200.00 to $203.77. The modest gain came alongside a disclosed institutional trim. AEGON Asset Management UK Plc lessened its position in NVIDIA Corporation (NASDAQ: NVDA) by 5.6% in the…